Skip to main content
SpringerLink
Log in
Book cover

Kompendium der Psychiatrischen Pharmakotherapie pp 782–817Cite as

Medikamente zur Behandlung von sexuellen Funktionsstörungen

  • Chapter

Zusammenfassung

Indikationen, Wirkungsweise, Nebenwirkungen und Risiken, Kontraindikationen und Interaktionen werden für die Medikamente zur Behandlung von sexuellen Funktionsstörungen im allgemeinen Teil und dann für jedes Arzneimittel spezifisch im Präparateteil beschrieben.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   49.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   64.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Literatur

  • Achilli C, Pundir J, Ramanathan P, Sabatini L et al (2017) Efficacy and safety of transdermal testosterone in postmenopausal women with hypoactive sexual desire disorder: a systematic review and meta-analysis. Fertil Steril 107(2): 475–482

    Article  Google Scholar 

  • Algeffari M, Jayasena CN, MacKeith P et al (2018) Testosterone therapy for sexual dysfunction in men with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Diabet Med 35(2): 195–202

    Article  Google Scholar 

  • Barton DL, Sloan JA, Shuster LT et al (2018) Evaluating the efficacy of vaginal dehydroepiandosterone for vaginal symptoms in postmenopausal cancer survivors: NCCTG N10C1 (Alliance). Support Care Cancer 26(2): 643–650

    Article  Google Scholar 

  • Berner M (2017) Psychopharmakaassoziierte sexuelle Funktionsstörungen und ihre Behandlung. Nervenarzt 88(5): 459–465

    Article  CAS  Google Scholar 

  • Castiglione F, Albersen M, Hedlund P et al (2016) Current pharmacological management of premature ejaculation: a systematic review and meta-analysis. Eur Urol 69(5): 904–916

    Article  CAS  Google Scholar 

  • Chokka PR, Hankey JR (2018) Assessment and management of sexual dysfunction in the context of depression. Ther Adv Psychopharmacol 8(1): 13–23

    Article  Google Scholar 

  • Clayton AH, Althof SE, Kingsberg S et al (2016) Bremelanotide for female sexual dysfunctions in premenopausal women: a randomized, placebo-controlled dose-finding trial. Womens Health (Lond) 12(3): 325–337

    Article  CAS  Google Scholar 

  • Clayton AH, Kingsberg SA, Goldstein I (2018) Evaluation and management of hypoactive sexual desire disorder. Sex Med 6(2): 59–74

    Article  Google Scholar 

  • Corona G, Rastrelli G, Burri A et al (2016a) The safety and efficacy of Avanafil, a new 2(nd) generation PDE5i: comprehensive review and meta-analysis. Expert Opin Drug Saf 15(2): 237–247

    Article  CAS  Google Scholar 

  • Corona G, Rastrelli G, Burri A et al (2016b) First-generation phosphodiesterase type 5 inhibitors dropout: a comprehensive review and meta-analysis. Andrology 4(6): 1002–1009

    Article  CAS  Google Scholar 

  • Corona G, Rastrelli G, Morgentaler A et al (2017) Meta-analysis of results of testosterone therapy on sexual function based on International Index of Erectile Function Scores. Eur Urol 72(6): 1000–1011

    Google Scholar 

  • de Boer MK, Castelein S, Wiersma D et al (2015) The facts about sexual (dys)function in schizophrenia: an overview of clinically relevant findings. Schizophr Bull 41: 674–686

    Google Scholar 

  • Fujioi J, Iwamoto K, Banno M et al (2017) Effect of adjunctive aripiprazole on sexual dysfunction in schizophrenia: a preliminary open-label study. Pharmacopsychiatry 50(2): 74–78

    Article  Google Scholar 

  • Gacci M, Andersson KE, Chapple C et al (2016) Latest evidence of the use of phosphodiesterase 5 inhibitors for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. Eur Urol 70(1): 124–133

    Article  CAS  Google Scholar 

  • Gao L, Yang L, Qian S et al (2016) Systematic review and meta-analysis of phosphodiesterase type 5 inhibitors for the treatment of female sexual dysfunction. Int J Gynaecol Obstet 133(2): 139–145

    Google Scholar 

  • Gong B, Ma M, Xie W et al (2017) Direct comparison of tadalafil with sildenafil for the treatment of erectile dysfunction: a systematic review and meta-analysis. Int Urol Nephrol 49(10): 1731–1740

    Article  CAS  Google Scholar 

  • Han X, Han Y, Zheng Y et al (2018) Use of phosphodiesterase type 5 inhibitors and risk of melanoma: a meta-analysis of observational studies. Onco Targets Ther 11: 711–720

    Article  Google Scholar 

  • Hong JH, Kwon YS, Kim IY (2017) Pharmacodynamics, pharmacokinetics and clinical efficacy of phosphodiesterase-5 inhibitors. Expert Opin Drug Metab Toxicol 13(2): 183–192

    Article  Google Scholar 

  • Hoyer J, Velten J (2017) Sexuelle Funktionsstörungen: Wandel der Sichtweisen und Klassifikationskriterien. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 60(9): 979–986

    Article  Google Scholar 

  • Jaspers L, Feys F, Bramer WM et al (2016) Efficacy and safety of flibanserin for the treatment of hypoactive sexual desire disorder in women: a systematic review and meta-analysis. JAMA Intern Med 176(4): 453–462

    Article  Google Scholar 

  • Kalejaiye O, Almekaty K, Blecher G, Minhas S (2017) Premature ejaculation: challenging new and the old concepts. F1000Res 6: 2084

    Article  Google Scholar 

  • Kirino E (2017) Serum prolactin levels and sexual dysfunction in patients with schizophrenia treated with antipsychotics: comparison between aripiprazole and other atypical antipsychotics. Ann Gen Psychiatry 16: 43

    Google Scholar 

  • La Torre A, Giupponi G, Duffy DM et al (2014) Sexual dysfunction related to psychotropic drugs: a critical review. Part III: mood stabilizers and anxiolytic drugs. Pharmacopsychiatry 47(1): 1–6

    Google Scholar 

  • La Torre A, Giupponi G, Duffy DM et al (2015) Sexual dysfunction related to drugs: a critical review. Part IV: cardiovascular drugs. Pharmacopsychiatry 48: 1–6

    Google Scholar 

  • Martyn-St James M, Cooper K, Ren S et al (2017) Phosphodiesterase type 5 inhibitors for premature ejaculation: a systematic review and meta-analysis. Eur Urol Focus 3(1): 119–129

    Article  Google Scholar 

  • McMahon CG (2016) Emerging and investigational drugs for premature ejaculation. Transl Androl Urol 5(4): 487–501

    Article  Google Scholar 

  • Montejo AL, Montejo L, Baldwin DS (2018) The impact of severe mental disorders and psychotropic medications on sexual health and its implications for clinical management. World Psychiatry 17(1): 3–11

    Article  Google Scholar 

  • Saroukhani S, Emami-Parsa M, Modabbernia A et al (2013) Aspirin for treatment of lithium-associated sexual dysfunction in men: randomized double-blind placebo-controlled study. Bipolar Disord 15(6): 650–656

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Berlin, Deutschland

    Prof. Dr. med. Dr. rer. nat. Dipl.-Psych. M. J. Müller

  2. Mainz, Deutschland

    Prof. Dr. med. O. Benkert

Authors
  1. Prof. Dr. med. Dr. rer. nat. Dipl.-Psych. M. J. Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. med. O. Benkert
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to M. J. Müller or O. Benkert .

Editor information

Editors and Affiliations

  1. Mainz, Deutschland

    O. Benkert

  2. München, Deutschland

    H. Hippius

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer-Verlag GmbH Deutschland

About this chapter

Cite this chapter

Müller, M.J., Benkert, O. (2019). Medikamente zur Behandlung von sexuellen Funktionsstörungen. In: Benkert, O., Hippius, H. (eds) Kompendium der Psychiatrischen Pharmakotherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-57334-1_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-57334-1_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-57333-4

  • Online ISBN: 978-3-662-57334-1

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation